Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes.
about
Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.PPAR Agonists and Cardiovascular Disease in Diabetes.Should We Use PPAR Agonists to Reduce Cardiovascular Risk?Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises.Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers.
P2860
Q36314862-B2C8F946-37C7-4405-8779-E115822541ACQ36444975-58E8CB4B-27F2-4C34-8811-D5782BE9774CQ36446970-FB8AFB01-7B67-4574-A8F3-2052DD9D2C21Q37827882-AEE8030C-D595-42DA-851C-810CAD1FF319Q39771912-C0B63DA0-D0C7-40FC-AE76-9AA5B0D975C1Q42288257-D19E3A98-C94A-45D9-A453-AB971345E9F1Q46438858-0AADADF8-84F5-4AAB-8B0E-46B4566D9D22
P2860
Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Ragaglitazar: the pharmacokine ...... patients with type 2 diabetes.
@en
Ragaglitazar: the pharmacokine ...... patients with type 2 diabetes.
@nl
type
label
Ragaglitazar: the pharmacokine ...... patients with type 2 diabetes.
@en
Ragaglitazar: the pharmacokine ...... patients with type 2 diabetes.
@nl
prefLabel
Ragaglitazar: the pharmacokine ...... patients with type 2 diabetes.
@en
Ragaglitazar: the pharmacokine ...... patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Ragaglitazar: the pharmacokine ...... patients with type 2 diabetes.
@en
P2093
P2860
P304
P356
10.1177/0091270003257230
P577
2003-11-01T00:00:00Z